| Summary | Values |
|---|---|
| Min | 1.00 |
| Quartile.1 | 1.00 |
| Median | 1.00 |
| Quartile.3 | 1.00 |
| Max | 10.00 |
| IQR | 0.00 |
| SD | 0.61 |
| Mean | 1.20 |
| Upper 95% CI | 2.42 |
| Lower 95% CI | -0.01 |
| Summary | Values |
|---|---|
| Min | 1.00 |
| Quartile.1 | 1.00 |
| Median | 1.00 |
| Quartile.3 | 1.00 |
| Max | 18.00 |
| IQR | 0.00 |
| SD | 1.23 |
| Mean | 1.45 |
| Upper 95% CI | 3.90 |
| Lower 95% CI | -1.01 |
| Ethnicity | Percentage (%) | Lower 95% CI | Upper 95% CI |
|---|---|---|---|
| Asian | 0.03 | 0.00 | 0.48 |
| Black | 92.30 | 91.85 | 92.76 |
| Coloured | 2.96 | 2.51 | 3.42 |
| Indian | 1.49 | 1.05 | 1.95 |
| Other | 0.16 | 0.00 | 0.62 |
| White | 3.06 | 2.61 | 3.51 |
| Gender | Percentage (%) | Lower 95% CI | Upper 95% CI |
|---|---|---|---|
| Female | 52.81 | 51.84 | 53.77 |
| Male | 47.14 | 46.17 | 48.11 |
| Other | 0.05 | 0.00 | 1.02 |
| Age Group | Percentage (%) | Lower 95% CI | Upper 95% CI |
|---|---|---|---|
| Infant | 0.28 | 0.00 | 1.27 |
| Preschool Child | 0.00 | 0.00 | 0.99 |
| Child | 1.48 | 0.49 | 2.46 |
| Adolescent | 4.02 | 3.03 | 5.00 |
| Young Adult | 6.00 | 5.02 | 6.99 |
| Adult | 34.09 | 33.11 | 35.08 |
| Middle Aged | 35.87 | 34.88 | 36.85 |
| Aged | 14.99 | 14.01 | 15.98 |
| 80+ | 3.28 | 2.29 | 4.26 |
7.97% of patient’s were assessed to have outlier length of stays. This was assessed by means of a cutoff of \(1.5*IQR\) below the first and above the third quartile.
3D Plot
2D Plot
| ICD Chapter | Percentage (%) | Lower 95% CI | Upper 95% CI |
|---|---|---|---|
| Infectious & Parasitic | 3.36 | 2.34 | 4.39 |
| Neoplasms | 18.67 | 17.65 | 19.71 |
| Blood & Immune | 0.48 | 0.00 | 1.51 |
| Endocrine, etc | 2.54 | 1.53 | 3.58 |
| Mental & Behavioural | 0.23 | 0.00 | 1.27 |
| Nervous System | 0.19 | 0.00 | 1.22 |
| Eye & Adnexa | 0.05 | 0.00 | 1.09 |
| Ear & Mastoid | 0.02 | 0.00 | 1.05 |
| Circulatory System | 5.37 | 4.35 | 6.40 |
| Respiratory System | 0.47 | 0.00 | 1.50 |
| Digestive System | 48.53 | 47.51 | 49.56 |
| Skin & Subcutaneous | 5.78 | 4.76 | 6.81 |
| Musculoskeletal | 1.15 | 0.13 | 2.18 |
| Genitourinary System | 2.96 | 1.94 | 3.99 |
| Pregnancy | 1.09 | 0.07 | 2.13 |
| Perinatal | 0.02 | 0.00 | 1.05 |
| Congenital | 0.45 | 0.00 | 1.48 |
| Abnormal Findings | 1.80 | 0.78 | 2.84 |
| Injury, Poisoning, etc | 1.00 | 0.00 | 2.03 |
| Morbidity & Mortality | 0.15 | 0.00 | 1.18 |
| Influencing Factors | 0.90 | 0.00 | 1.93 |
| Special Purpose | 0.01 | 0.00 | 1.04 |
| Neoplasm Morphology | 4.78 | 3.76 | 5.82 |
Waiting for profiling to be done...
Waiting for profiling to be done...
Analysis of predictors of a length of stay greater than 5 days in a surgical ward at a Wits institution.
| Fields | 5 or Less | More than 5 |
|---|---|---|
| Female | 2760 | 3356 |
| Male | 2176 | 3296 |
| Other | 3 | 2 |
| Fields | 5 or Less | More than 5 |
|---|---|---|
| Asian | 3 | 0 |
| Black | 4535 | 6132 |
| Coloured | 143 | 206 |
| Indian | 92 | 89 |
| Other | 9 | 6 |
| White | 157 | 221 |
| Fields | 5 or Less | More than 5 |
|---|---|---|
| Infant | 14 | 13 |
| Preschool Child | 0 | 0 |
| Child | 105 | 59 |
| Adolescent | 263 | 195 |
| Young Adult | 407 | 264 |
| Adult | 1859 | 2025 |
| Middle Aged | 1540 | 2665 |
| Aged | 595 | 1189 |
| 80+ | 156 | 244 |
| Fields | 5 or Less | More than 5 |
|---|---|---|
| Burns Unit | 0 | 1 |
| Trauma Unit | 0 | 2 |
| Unit 1 | 1552 | 2270 |
| Unit 3 | 1225 | 1914 |
| Unit 4 | 1043 | 815 |
| Unit 5 | 824 | 1150 |
| Unknown | 245 | 305 |
| Vascular | 50 | 197 |
| Fields | 5 or Less | More than 5 |
|---|---|---|
| Declined Treatment | 16 | 25 |
| Demised | 0 | 1 |
| Home | 4144 | 5531 |
| Other | 619 | 793 |
| Transfer | 160 | 304 |
| Fields | 5 or Less | More than 5 |
|---|---|---|
| Infectious & Parasitic | 114 | 228 |
| Neoplasms | 590 | 1326 |
| Blood & Immune | 17 | 33 |
| Endocrine, etc | 68 | 188 |
| Mental & Behavioural | 13 | 10 |
| Nervous System | 7 | 12 |
| Eye & Adnexa | 2 | 3 |
| Ear & Mastoid | 1 | 1 |
| Circulatory System | 161 | 363 |
| Respiratory System | 16 | 30 |
| Digestive System | 2182 | 2650 |
| Skin & Subcutaneous | 355 | 212 |
| Musculoskeletal | 38 | 88 |
| Genitourinary System | 187 | 106 |
| Pregnancy | 81 | 24 |
| Perinatal | 0 | 2 |
| Congenital | 16 | 27 |
| Abnormal Findings | 91 | 90 |
| Injury, Poisoning, etc | 51 | 49 |
| Morbidity & Mortality | 8 | 6 |
| Influencing Factors | 29 | 58 |
| Special Purpose | 0 | 2 |
| Neoplasm Morphology | 136 | 364 |
| Fields | 5 or Less | More than 5 |
|---|---|---|
| (A00-A09) Intestinal infectious diseases | 17 | 51 |
| (A15-A19) Tuberculosis | 14 | 38 |
| (A20-A28) Certain zoonotic bacterial diseases | 0 | 1 |
| (A30-A49) Other bacterial diseases | 7 | 33 |
| (A50-A64) Infections with a predominantly sexual mode of transmission | 18 | 16 |
| (A65-A69) Other spirochaetal diseases | 1 | 0 |
| (A80-A89) Viral infections of the central nervous system | 0 | 1 |
| (B00-B09) Viral infections characterized by skin and mucous membrane lesions | 3 | 0 |
| (B15-B19) Viral hepatitis | 6 | 5 |
| (B20-B24) Human immunodeficiency virus [HIV] disease | 15 | 46 |
| (B25-B34) Other viral diseases | 0 | 2 |
| (B35-B49) Mycoses | 10 | 4 |
| (B65-B83) Helminthiases | 4 | 15 |
| (B95-B98) Bacterial, viral and other infectious agents | 3 | 11 |
| (B99) Other infectious diseases | 16 | 5 |
| (C00-C14) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Lip, oral cavity and pharynx | 0 | 1 |
| (C15-C26) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Digestive organs | 270 | 919 |
| (C30-C39) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Respiratory and intrathoracic organs | 0 | 2 |
| (C40-C41) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Bone and articular cartilage | 0 | 1 |
| (C43-C44) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Skin | 2 | 19 |
| (C45-C49) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Mesothelial and soft tissue | 9 | 17 |
| (C50) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Breast | 180 | 185 |
| (C51-C57) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Female genital organs | 10 | 21 |
| (C60-C63) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Male genital organs | 5 | 4 |
| (C64-C68) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Urinary tract | 0 | 2 |
| (C69-C72) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Eye, brain and other parts of central nervous system | 0 | 1 |
| (C73-C75) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Thyroid and other endocrine glands | 16 | 17 |
| (C76-C80) Malignant neoplasms of ill-defined, secondary and unspecified sites | 3 | 6 |
| (C81-C96) Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue | 2 | 9 |
| (C97) Malignant neoplasms of independent (primary) multiple sites | 0 | 2 |
| (D00-D09) In situ neoplasms | 12 | 30 |
| (D10-D36) Benign neoplasms | 58 | 54 |
| (D37-D48) Neoplasms of uncertain or unknown behaviour [see note, page 226] | 23 | 36 |
| (D50-D53) Nutritional anaemias | 13 | 15 |
| (D55-D59) Haemolytic anaemias | 2 | 2 |
| (D60-D64) Aplastic and other anaemias | 0 | 1 |
| (D65-D69) Coagulation defects, purpura and other haemorrhagic conditions | 1 | 2 |
| (D70-D77) Other diseases of blood and blood-forming organs | 1 | 11 |
| (D80-D89) Certain disorders involving the immune mechanism | 0 | 2 |
| (E00-E07) Disorders of thyroid gland | 28 | 43 |
| (E10-E14) Diabetes mellitus | 30 | 113 |
| (E15-E16) Other disorders of glucose regulation and pancreatic internal secretion | 1 | 3 |
| (E20-E35) Disorders of other endocrine glands | 6 | 23 |
| (E70-E90) Metabolic disorders | 3 | 6 |
| (F00-F09) Organic, including symptomatic, mental disorders | 1 | 2 |
| (F10-F19) Mental and behavioural disorders due to psychoactive substance use | 3 | 0 |
| (F20-F29) Schizophrenia, schizotypal and delusional disorders | 0 | 1 |
| (F30-F39) Mood [affective] disorders | 3 | 1 |
| (F40-F48) Neurotic, stress-related and somatoform disorders | 0 | 1 |
| (F50-F59) Behavioural syndromes associated with physiological disturbances and physical factors | 1 | 0 |
| (F70-F79) Mental retardation | 0 | 2 |
| (F90-F98) Behavioural and emotional disorders with onset usually occurring in childhood and adolescence | 1 | 0 |
| (F99) Unspecified mental disorder | 4 | 3 |
| (G00-G09) Inflammatory diseases of the central nervous system | 3 | 3 |
| (G10-G14) Systemic atrophies primarily affecting the central nervous system | 0 | 2 |
| (G40-G47) Episodic and paroxysmal disorders | 0 | 2 |
| (G50-G59) Nerve, nerve root and plexus disorders | 2 | 0 |
| (G70-G73) Diseases of myoneural junction and muscle | 1 | 3 |
| (G80-G83) Cerebral palsy and other paralytic syndromes | 1 | 1 |
| (G90-G99) Other disorders of the nervous system | 0 | 1 |
| (H00-H06) Disorders of eyelid, lacrimal system and orbit | 2 | 0 |
| (H25-H28) Disorders of lens | 0 | 2 |
| (H46-H48) Disorders of optic nerve and visual pathways | 0 | 1 |
| (H60-H62) Diseases of external ear | 1 | 0 |
| (H90-H95) Other disorders of ear | 0 | 1 |
| (I05-I09) Chronic rheumatic heart diseases | 3 | 1 |
| (I10-I15) Hypertensive diseases | 44 | 87 |
| (I20-I25) Ischaemic heart diseases | 1 | 4 |
| (I26-I28) Pulmonary heart disease and diseases of pulmonary circulation | 2 | 10 |
| (I30-I52) Other forms of heart disease | 6 | 7 |
| (I60-I69) Cerebrovascular diseases | 0 | 4 |
| (I70-I79) Diseases of arteries, arterioles and capillaries | 41 | 171 |
| (I80-H89) Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | 60 | 73 |
| (I95-I99) Other and unspecified disorders of the circulatory system | 4 | 6 |
| (J00-J06) Acute upper respiratory infections | 1 | 0 |
| (J09-J18) Influenza and pneumonia | 1 | 7 |
| (J20-J22) Other acute lower respiratory infections | 0 | 2 |
| (J30-J39) Other diseases of upper respiratory tract | 1 | 2 |
| (J40-J47) Chronic lower respiratory diseases | 7 | 8 |
| (J80-J84) Other respiratory diseases principally affecting the interstitium | 0 | 1 |
| (J85-J94) Other diseases of pleura | 2 | 6 |
| (J85-J94) Suppurative and necrotic conditions of lower respiratory tract | 4 | 3 |
| (J95-J99) Other diseases of the respiratory system | 0 | 1 |
| (K00-K14) Diseases of oral cavity, salivary glands and jaws | 3 | 2 |
| (K20-K31) Diseases of oesophagus, stomach and duodenum | 372 | 396 |
| (K35-K38) Diseases of appendix | 408 | 452 |
| (K40-K46) Hernia | 341 | 256 |
| (K50-K52) Noninfective enteritis and colitis | 13 | 12 |
| (K55-K64) Other diseases of intestines | 282 | 361 |
| (K65-K67) Diseases of peritoneum | 2 | 15 |
| (K70-K77) Diseases of liver | 9 | 72 |
| (K80-K87) Disorders of gallbladder, biliary tract and pancreas | 669 | 994 |
| (K90-K93) Other diseases of the digestive system | 83 | 90 |
| (L00-L08) Infections of the skin and subcutaneous tissue | 330 | 180 |
| (L10-L14) Bullous disorders | 1 | 1 |
| (L60-L75) Disorders of skin appendages | 3 | 5 |
| (L80-L99) Other disorders of the skin and subcutaneous tissue | 21 | 26 |
| (M00-M25) Arthropathies: Arthrosis | 1 | 1 |
| (M00-M25) Arthropathies: Infectious arthropathies | 0 | 3 |
| (M00-M25) Arthropathies: Inflammatory polyarthropathies | 4 | 5 |
| (M00-M25) Arthropathies: Other joint disorders | 0 | 2 |
| (M30-M36) Systemic connective tissue disorders | 2 | 1 |
| (M40-M54) Dorsopathies: Deforming dorsopathies | 4 | 1 |
| (M60-M79) Soft tissue disorders: Disorders of muscles | 5 | 10 |
| (M60-M79) Soft tissue disorders: Disorders of synovium and tendon | 2 | 1 |
| (M60-M79) Soft tissue disorders: Other soft tissue disorders | 16 | 57 |
| (M80-M94) Osteopathies and chondropathies: Chondropathies | 1 | 0 |
| (M80-M94) Osteopathies and chondropathies: Other osteopathies | 2 | 3 |
| (M800) Morphology Classification: Neoplasms, NOS | 6 | 26 |
| (M801-M804) Morphology Classification: Neoplasms, NOS | 3 | 11 |
| (M805-M808) Morphology Classification: Squamous cell neoplasms | 15 | 44 |
| (M809-M811) Morphology Classification: Basal cell neoplasms | 0 | 2 |
| (M812-M813) Morphology Classification: Transitional cell papillomas and carcinomas | 0 | 1 |
| (M814-M838) Morphology Classification: Adenomas and adenocarcinomas | 71 | 213 |
| (M844-M849) Morphology Classification: Cystic, mucinous and serous neoplasms | 4 | 3 |
| (M850-M854) Morphology Classification: Ductal and lobular neoplasms | 0 | 2 |
| (M868-M871) Morphology Classification: Paragangliomas and glomus tumours | 0 | 3 |
| (M872-M879) Morphology Classification: Naevi and melanomas | 0 | 2 |
| (M880) Morphology Classification: | 3 | 6 |
| (M881-M883) Morphology Classification: Fibromatous neoplasms | 3 | 12 |
| (M884) Morphology Classification: Myxomatous neoplasms | 0 | 1 |
| (M885-M888) Morphology Classification: Lipomatous neoplasms | 3 | 3 |
| (M889-M892) Morphology Classification: Myomatous neoplasms | 0 | 1 |
| (M893-M899) Morphology Classification: Complex mixed and stromal neoplasms | 2 | 18 |
| (M900-M903) Morphology Classification: Fibroepithelial neoplasms | 23 | 6 |
| (M904) Morphology Classification: Synovial-like neoplasms | 0 | 1 |
| (M906-M909) Morphology Classification: Germ cell neoplasms | 0 | 2 |
| (M912-M916) Morphology Classification: Blood vessel tumours | 0 | 1 |
| (M918-M924) Morphology Classification: Osseous and chondromatous neoplasms | 1 | 0 |
| (M95-M99) Other disorders of the musculoskeletal system and connective tissue | 1 | 4 |
| (M954-M957) Morphology Classification: Nerve sheath tumours | 1 | 2 |
| (M959-M971) Morphology Classification: Hodgkin and non-Hodgkin lymphoma | 0 | 3 |
| (M995-M997) Morphology Classification: Chronic myeloprpliferative disorders | 1 | 1 |
| (N10-N16) Renal tubulo-interstitial diseases | 5 | 11 |
| (N17-N19) Renal failure | 5 | 23 |
| (N20-N23) Urolithiasis | 0 | 1 |
| (N25-N29) Other disorders of kidney and ureter | 2 | 2 |
| (N30-N39) Other diseases of urinary system | 15 | 10 |
| (N40-N51) Diseases of male genital organs | 9 | 11 |
| (N60-N64) Disorders of breast | 119 | 15 |
| (N70-N77) Inflammatory diseases of female pelvic organs | 15 | 12 |
| (N80-N98) Noninflammatory disorders of female genital tract | 17 | 21 |
| (O00-O08) Pregnancy with abortive outcome | 0 | 6 |
| (O20-O29) Other maternal disorders predominantly related to pregnancy | 2 | 1 |
| (O60-O75) Complications of labour and delivery | 2 | 4 |
| (O80-O84) Delivery | 0 | 1 |
| (O85-O92) Complications predominantly related to the puerperium | 77 | 12 |
| (P80-P83) Conditions involving the integument and temperature regulation of fetus and newborn | 0 | 1 |
| (P90-P96) Other disorders originating in the perinatal period | 0 | 1 |
| (Q10-Q18) Congenital malformations of eye, ear, face and neck | 2 | 0 |
| (Q20-Q28) Congenital malformations of the circulatory system | 0 | 1 |
| (Q38-Q45) Other congenital malformations of the digestive system | 9 | 16 |
| (Q50-Q56) Congenital malformations of genital organs | 1 | 3 |
| (Q80-Q89) Other congenital malformations | 3 | 6 |
| (Q90-Q99) Chromosomal abnormalities, not elsewhere classified | 1 | 1 |
| (R00-R09) Symptoms and signs involving the circulatory and respiratory systems | 1 | 0 |
| (R10-R19) Symptoms and signs involving the digestive system and abdomen | 75 | 66 |
| (R20-R23) Symptoms and signs involving the skin and subcutaneous tissue | 14 | 9 |
| (R30-R39) Symptoms and signs involving the urinary system | 0 | 1 |
| (R50-R69) General symptoms and signs | 0 | 7 |
| (R70-R79) Abnormal findings on examination of blood, without diagnosis | 0 | 1 |
| (R83-R89) Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis | 1 | 0 |
| (R90-R94) Abnormal findings on diagnostic imaging and in function studies, without diagnosis | 0 | 6 |
| (S00-S09) Injuries to the head | 1 | 0 |
| (S10-S19) Injuries to the neck | 1 | 0 |
| (S20-S29) Injuries to the thorax | 0 | 1 |
| (S30-S39) Injuries to the abdomen, lower back, lumbar spine and pelvis | 5 | 25 |
| (S40-S49) Injuries to the shoulder and upper arm | 1 | 0 |
| (S70-S79) Injuries to the hip and thigh | 0 | 2 |
| (S80-S89) Injuries to the knee and lower leg | 1 | 2 |
| (S90-S99) Injuries to the ankle and foot | 2 | 0 |
| (T00-T07) Injuries involving multiple body regions | 1 | 0 |
| (T15-T19) Effects of foreign body entering through natural orifice | 5 | 0 |
| (T20-T32) Burns and corrosions: Burns and corrosions confined to eye and internal organs | 0 | 1 |
| (T20-T32) Burns and corrosions: Burns and corrosions of external body surface, specified by site | 3 | 0 |
| (T36-T50) Poisoning by drugs, medicaments and biological substances | 10 | 2 |
| (T51-T65) Toxic effects of substances chiefly nonmedicinal as to source | 17 | 2 |
| (T80-T88) Complications of surgical and medical care, not elsewhere classified | 4 | 14 |
| (U50) Drug resistant tuberculosis | 0 | 2 |
| (V01-V09) Accidents: Transport accidents: Pedestrian injured in transport accident | 0 | 1 |
| (W75-W84) Accidents: Other external causes of accidental injury: Other accidental threats to breathing | 3 | 1 |
| (X40-X49) Accidents: Other external causes of accidental injury: Accidental poisoning by and exposure to noxious substances | 0 | 1 |
| (X60-X84) Intentional self-harm | 5 | 1 |
| (X85-Y09) Assault | 0 | 1 |
| (Y83-Y84) Complications of medical and surgical care: Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure | 0 | 1 |
| (Z00-Z13) Persons encountering health services for examination and investigation | 1 | 1 |
| (Z40-Z54) Persons encountering health services for specific procedures and health care | 5 | 21 |
| (Z70-Z76) Persons encountering health services in other circumstances | 1 | 0 |
| (Z80-Z99) Persons with potential health hazards related to family and personal history and certain conditions influencing health status | 22 | 36 |
| Variable | OR | 2.5% | 97.5% | p Val | |
|---|---|---|---|---|---|
| (Intercept) | 1.20 | 1.15 | 1.27 | 0.0000 | *** |
| genderMale | 1.25 | 1.16 | 1.35 | 0.0000 | *** |
| genderOther | 0.55 | 0.07 | 3.34 | 0.5172 |
|
| Elements | Results | |
|---|---|---|
| Chi Squared | 3.560448e+01 |
|
| Degrees of Freedom | 2.000000e+00 |
|
| p Value | 1.856029e-08 | *** |
| Variable | OR | 2.5% | 97.5% | p Val | |
|---|---|---|---|---|---|
| (Intercept) | 1.34 | 1.29 | 1.39 | 0.0000 | *** |
| ethnicityColoured | 1.07 | 0.87 | 1.34 | 0.5185 |
|
| ethnicityIndian | 0.73 | 0.54 | 0.98 | 0.0366 | * |
| ethnicityOther | 0.50 | 0.17 | 1.38 | 0.1850 |
|
| ethnicityWhite | 1.03 | 0.83 | 1.27 | 0.8117 |
|
| Elements | Results | |
|---|---|---|
| Chi Squared | 6.6697527 |
|
| Degrees of Freedom | 4.0000000 |
|
| p Value | 0.1544039 |
|
| Variable | OR | 2.5% | 97.5% | p Val | |
|---|---|---|---|---|---|
| (Intercept) | 1.04 | 0.93 | 1.17 | 0.4605 |
|
| Age_Group.L | 2.72 | 1.74 | 4.26 | 0.0000 | *** |
| Age_Group.Q | 1.34 | 0.86 | 2.06 | 0.1852 |
|
| Age_Group.C | 0.53 | 0.37 | 0.77 | 0.0007 | *** |
| Age_Group^4 | 0.90 | 0.67 | 1.20 | 0.4701 |
|
| Age_Group^5 | 0.93 | 0.75 | 1.16 | 0.5419 |
|
| Age_Group^6 | 1.27 | 1.08 | 1.50 | 0.0045 | ** |
| Age_Group^7 | 0.86 | 0.76 | 0.98 | 0.0279 | * |
| Elements | Results | |
|---|---|---|
| Chi Squared | 320.0487 |
|
| Degrees of Freedom | 7.0000 |
|
| p Value | 0.0000 | *** |
| Variable | OR | 2.5% | 97.5% | p Val | |
|---|---|---|---|---|---|
| (Intercept) | 1.45 | 1.36 | 1.55 | 0.0000 | *** |
| dischargeWardUnit 3 | 1.07 | 0.97 | 1.18 | 0.1842 |
|
| dischargeWardUnit 4 | 0.53 | 0.48 | 0.60 | 0.0000 | *** |
| dischargeWardUnit 5 | 0.95 | 0.85 | 1.06 | 0.3642 |
|
| dischargeWardUnknown | 0.84 | 0.70 | 1.01 | 0.0616 | . |
| dischargeWardVascular | 2.71 | 1.98 | 3.77 | 0.0000 | *** |
| Elements | Results | |
|---|---|---|
| Chi Squared | 204.2357 |
|
| Degrees of Freedom | 5.0000 |
|
| p Value | 0.0000 | *** |
| Variable | OR | 2.5% | 97.5% | p Val | |
|---|---|---|---|---|---|
| (Intercept) | 1.56 | 0.84 | 2.98 | 0.1633 |
|
| dischargeTypeHome | 0.85 | 0.44 | 1.57 | 0.6044 |
|
| dischargeTypeOther | 0.82 | 0.43 | 1.54 | 0.5516 |
|
| dischargeTypeTransfer | 1.20 | 0.61 | 2.29 | 0.5880 |
|
| Elements | Results | |
|---|---|---|
| Chi Squared | 12.691636809 |
|
| Degrees of Freedom | 3.000000000 |
|
| p Value | 0.005353211 | ** |
| Variable | OR | 2.5% | 97.5% | p Val | |
|---|---|---|---|---|---|
| (Intercept) | 1.22 | 1.05 | 1.40 | 0.0059 | ** |
| ICD_Chapter_Short.L | 0.36 | 0.18 | 0.67 | 0.0018 | ** |
| ICD_Chapter_Short.Q | 2.80 | 1.79 | 4.25 | 0.0000 | *** |
| ICD_Chapter_Short.C | 2.67 | 1.56 | 4.59 | 0.0003 | *** |
| ICD_Chapter_Short^4 | 1.68 | 0.97 | 3.13 | 0.0755 | . |
| ICD_Chapter_Short^5 | 1.15 | 0.61 | 2.39 | 0.6826 |
|
| ICD_Chapter_Short^6 | 1.13 | 0.60 | 2.24 | 0.7110 |
|
| ICD_Chapter_Short^7 | 1.84 | 1.16 | 2.93 | 0.0095 | ** |
| ICD_Chapter_Short^8 | 0.86 | 0.51 | 1.42 | 0.5597 |
|
| ICD_Chapter_Short^9 | 0.39 | 0.18 | 0.81 | 0.0139 | * |
| ICD_Chapter_Short^10 | 0.46 | 0.19 | 0.99 | 0.0586 | . |
| ICD_Chapter_Short^11 | 0.37 | 0.16 | 0.78 | 0.0135 | * |
| ICD_Chapter_Short^12 | 0.53 | 0.25 | 1.08 | 0.0868 | . |
| ICD_Chapter_Short^13 | 2.61 | 1.43 | 4.63 | 0.0012 | ** |
| ICD_Chapter_Short^14 | 0.60 | 0.31 | 1.12 | 0.1086 |
|
| ICD_Chapter_Short^15 | 0.43 | 0.21 | 0.87 | 0.0173 | * |
| ICD_Chapter_Short^16 | 0.28 | 0.15 | 0.52 | 0.0001 | *** |
| ICD_Chapter_Short^17 | 0.76 | 0.46 | 1.28 | 0.3013 |
|
| ICD_Chapter_Short^18 | 1.60 | 1.13 | 2.26 | 0.0072 | ** |
| Elements | Results | |
|---|---|---|
| Chi Squared | 437.0637 |
|
| Degrees of Freedom | 18.0000 |
|
| p Value | 0.0000 | *** |
| Variable | OR | 2.5% | 97.5% | p Val | |
|---|---|---|---|---|---|
| (Intercept) | 2.94 | 1.73 | 5.25 | 0.0001 | *** |
| ICD_Title(A15-A19) Tuberculosis | 0.92 | 0.41 | 2.12 | 0.8485 |
|
| ICD_Title(A30-A49) Other bacterial diseases | 1.60 | 0.62 | 4.53 | 0.3473 |
|
| ICD_Title(A50-A64) Infections with a predominantly sexual mode of transmission | 0.30 | 0.12 | 0.72 | 0.0070 | ** |
| ICD_Title(B15-B19) Viral hepatitis | 0.28 | 0.07 | 1.05 | 0.0588 | . |
| ICD_Title(B20-B24) Human immunodeficiency virus [HIV] disease | 1.04 | 0.47 | 2.34 | 0.9186 |
|
| ICD_Title(B35-B49) Mycoses | 0.14 | 0.03 | 0.46 | 0.0023 | ** |
| ICD_Title(B65-B83) Helminthiases | 1.28 | 0.40 | 4.94 | 0.6993 |
|
| ICD_Title(B95-B98) Bacterial, viral and other infectious agents | 1.25 | 0.34 | 5.99 | 0.7559 |
|
| ICD_Title(B99) Other infectious diseases | 0.11 | 0.03 | 0.32 | 0.0001 | *** |
| ICD_Title(C15-C26) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Digestive organs | 1.16 | 0.64 | 2.00 | 0.6135 |
|
| ICD_Title(C43-C44) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Skin | 3.23 | 0.82 | 21.60 | 0.1400 |
|
| ICD_Title(C45-C49) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Mesothelial and soft tissue | 0.64 | 0.24 | 1.75 | 0.3746 |
|
| ICD_Title(C50) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Breast | 0.35 | 0.19 | 0.62 | 0.0004 | *** |
| ICD_Title(C51-C57) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Female genital organs | 0.71 | 0.28 | 1.85 | 0.4790 |
|
| ICD_Title(C60-C63) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Male genital organs | 0.27 | 0.06 | 1.14 | 0.0734 | . |
| ICD_Title(C73-C75) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Thyroid and other endocrine glands | 0.36 | 0.15 | 0.86 | 0.0229 | * |
| ICD_Title(C76-C80) Malignant neoplasms of ill-defined, secondary and unspecified sites | 0.68 | 0.16 | 3.50 | 0.6122 |
|
| ICD_Title(C81-C96) Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue | 3.06 | 0.52 | 58.53 | 0.3052 |
|
| ICD_Title(D00-D09) In situ neoplasms | 0.85 | 0.36 | 2.05 | 0.7132 |
|
| ICD_Title(D10-D36) Benign neoplasms | 0.32 | 0.16 | 0.61 | 0.0007 | *** |
| ICD_Title(D37-D48) Neoplasms of uncertain or unknown behaviour [see note, page 226] | 0.53 | 0.25 | 1.13 | 0.1035 |
|
| ICD_Title(D50-D53) Nutritional anaemias | 0.39 | 0.15 | 0.99 | 0.0472 | * |
| ICD_Title(D55-D59) Haemolytic anaemias | 0.34 | 0.04 | 3.01 | 0.2990 |
|
| ICD_Title(D65-D69) Coagulation defects, purpura and other haemorrhagic conditions | 0.68 | 0.06 | 15.17 | 0.7589 |
|
| ICD_Title(D70-D77) Other diseases of blood and blood-forming organs | 3.74 | 0.65 | 70.89 | 0.2224 |
|
| ICD_Title(E00-E07) Disorders of thyroid gland | 0.52 | 0.25 | 1.07 | 0.0800 | . |
| ICD_Title(E10-E14) Diabetes mellitus | 1.28 | 0.64 | 2.51 | 0.4770 |
|
| ICD_Title(E15-E16) Other disorders of glucose regulation and pancreatic internal secretion | 1.02 | 0.12 | 21.38 | 0.9867 |
|
| ICD_Title(E20-E35) Disorders of other endocrine glands | 1.30 | 0.47 | 4.00 | 0.6221 |
|
| ICD_Title(E70-E90) Metabolic disorders | 0.68 | 0.16 | 3.50 | 0.6122 |
|
| ICD_Title(F00-F09) Organic, including symptomatic, mental disorders | 0.68 | 0.06 | 15.17 | 0.7589 |
|
| ICD_Title(F30-F39) Mood [affective] disorders | 0.11 | 0.01 | 0.95 | 0.0669 | . |
| ICD_Title(F99) Unspecified mental disorder | 0.26 | 0.05 | 1.27 | 0.0931 | . |
| ICD_Title(G00-G09) Inflammatory diseases of the central nervous system | 0.34 | 0.06 | 1.99 | 0.2115 |
|
| ICD_Title(G70-G73) Diseases of myoneural junction and muscle | 1.02 | 0.12 | 21.38 | 0.9867 |
|
| ICD_Title(G80-G83) Cerebral palsy and other paralytic syndromes | 0.34 | 0.01 | 8.91 | 0.4543 |
|
| ICD_Title(I05-I09) Chronic rheumatic heart diseases | 0.11 | 0.01 | 0.95 | 0.0669 | . |
| ICD_Title(I10-I15) Hypertensive diseases | 0.67 | 0.34 | 1.28 | 0.2376 |
|
| ICD_Title(I20-I25) Ischaemic heart diseases | 1.36 | 0.18 | 27.59 | 0.7897 |
|
| ICD_Title(I26-I28) Pulmonary heart disease and diseases of pulmonary circulation | 1.70 | 0.40 | 11.78 | 0.5196 |
|
| ICD_Title(I30-I52) Other forms of heart disease | 0.40 | 0.12 | 1.38 | 0.1379 |
|
| ICD_Title(I70-I79) Diseases of arteries, arterioles and capillaries | 1.42 | 0.73 | 2.68 | 0.2902 |
|
| ICD_Title(I80-H89) Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | 0.41 | 0.21 | 0.78 | 0.0076 | ** |
| ICD_Title(I95-I99) Other and unspecified disorders of the circulatory system | 0.51 | 0.13 | 2.19 | 0.3388 |
|
| ICD_Title(J09-J18) Influenza and pneumonia | 2.38 | 0.38 | 46.17 | 0.4327 |
|
| ICD_Title(J30-J39) Other diseases of upper respiratory tract | 0.68 | 0.06 | 15.17 | 0.7589 |
|
| ICD_Title(J40-J47) Chronic lower respiratory diseases | 0.39 | 0.12 | 1.26 | 0.1084 |
|
| ICD_Title(J85-J94) Other diseases of pleura | 1.02 | 0.21 | 7.41 | 0.9817 |
|
| ICD_Title(J85-J94) Suppurative and necrotic conditions of lower respiratory tract | 0.26 | 0.05 | 1.27 | 0.0931 | . |
| ICD_Title(K00-K14) Diseases of oral cavity, salivary glands and jaws | 0.23 | 0.03 | 1.48 | 0.1202 |
|
| ICD_Title(K20-K31) Diseases of oesophagus, stomach and duodenum | 0.36 | 0.20 | 0.62 | 0.0004 | *** |
| ICD_Title(K35-K38) Diseases of appendix | 0.38 | 0.21 | 0.65 | 0.0007 | *** |
| ICD_Title(K40-K46) Hernia | 0.26 | 0.14 | 0.45 | 0.0000 | *** |
| ICD_Title(K50-K52) Noninfective enteritis and colitis | 0.31 | 0.12 | 0.81 | 0.0178 | * |
| ICD_Title(K55-K64) Other diseases of intestines | 0.44 | 0.24 | 0.76 | 0.0044 | ** |
| ICD_Title(K65-K67) Diseases of peritoneum | 2.55 | 0.63 | 17.24 | 0.2440 |
|
| ICD_Title(K70-K77) Diseases of liver | 2.72 | 1.15 | 6.85 | 0.0267 | * |
| ICD_Title(K80-K87) Disorders of gallbladder, biliary tract and pancreas | 0.50 | 0.28 | 0.86 | 0.0165 | * |
| ICD_Title(K90-K93) Other diseases of the digestive system | 0.37 | 0.19 | 0.68 | 0.0018 | ** |
| ICD_Title(L00-L08) Infections of the skin and subcutaneous tissue | 0.19 | 0.10 | 0.32 | 0.0000 | *** |
| ICD_Title(L10-L14) Bullous disorders | 0.34 | 0.01 | 8.91 | 0.4543 |
|
| ICD_Title(L60-L75) Disorders of skin appendages | 0.57 | 0.13 | 2.99 | 0.4679 |
|
| ICD_Title(L80-L99) Other disorders of the skin and subcutaneous tissue | 0.42 | 0.19 | 0.93 | 0.0331 | * |
| ICD_Title(M00-M25) Arthropathies: Arthrosis | 0.34 | 0.01 | 8.91 | 0.4543 |
|
| ICD_Title(M00-M25) Arthropathies: Inflammatory polyarthropathies | 0.43 | 0.10 | 1.89 | 0.2393 |
|
| ICD_Title(M30-M36) Systemic connective tissue disorders | 0.17 | 0.01 | 1.88 | 0.1585 |
|
| ICD_Title(M40-M54) Dorsopathies: Deforming dorsopathies | 0.09 | 0.00 | 0.62 | 0.0325 | * |
| ICD_Title(M60-M79) Soft tissue disorders: Disorders of muscles | 0.68 | 0.21 | 2.44 | 0.5309 |
|
| ICD_Title(M60-M79) Soft tissue disorders: Disorders of synovium and tendon | 0.17 | 0.01 | 1.88 | 0.1585 |
|
| ICD_Title(M60-M79) Soft tissue disorders: Other soft tissue disorders | 1.21 | 0.55 | 2.66 | 0.6306 |
|
| ICD_Title(M80-M94) Osteopathies and chondropathies: Other osteopathies | 0.51 | 0.08 | 4.12 | 0.4808 |
|
| ICD_Title(M800) Morphology Classification: Neoplasms, NOS | 1.47 | 0.54 | 4.49 | 0.4671 |
|
| ICD_Title(M801-M804) Morphology Classification: Neoplasms, NOS | 1.25 | 0.34 | 5.99 | 0.7559 |
|
| ICD_Title(M805-M808) Morphology Classification: Squamous cell neoplasms | 1.00 | 0.45 | 2.25 | 0.9948 |
|
| ICD_Title(M814-M838) Morphology Classification: Adenomas and adenocarcinomas | 1.03 | 0.55 | 1.88 | 0.9135 |
|
| ICD_Title(M844-M849) Morphology Classification: Cystic, mucinous and serous neoplasms | 0.26 | 0.05 | 1.27 | 0.0931 | . |
| ICD_Title(M880) Morphology Classification: | 0.68 | 0.16 | 3.50 | 0.6122 |
|
| ICD_Title(M881-M883) Morphology Classification: Fibromatous neoplasms | 1.36 | 0.38 | 6.48 | 0.6622 |
|
| ICD_Title(M885-M888) Morphology Classification: Lipomatous neoplasms | 0.34 | 0.06 | 1.99 | 0.2115 |
|
| ICD_Title(M893-M899) Morphology Classification: Complex mixed and stromal neoplasms | 3.06 | 0.77 | 20.51 | 0.1602 |
|
| ICD_Title(M900-M903) Morphology Classification: Fibroepithelial neoplasms | 0.09 | 0.03 | 0.24 | 0.0000 | *** |
| ICD_Title(M95-M99) Other disorders of the musculoskeletal system and connective tissue | 1.36 | 0.18 | 27.59 | 0.7897 |
|
| ICD_Title(M954-M957) Morphology Classification: Nerve sheath tumours | 0.68 | 0.06 | 15.17 | 0.7589 |
|
| ICD_Title(M995-M997) Morphology Classification: Chronic myeloprpliferative disorders | 0.34 | 0.01 | 8.91 | 0.4543 |
|
| ICD_Title(N10-N16) Renal tubulo-interstitial diseases | 0.75 | 0.23 | 2.65 | 0.6330 |
|
| ICD_Title(N17-N19) Renal failure | 1.56 | 0.54 | 5.22 | 0.4308 |
|
| ICD_Title(N25-N29) Other disorders of kidney and ureter | 0.34 | 0.04 | 3.01 | 0.2990 |
|
| ICD_Title(N30-N39) Other diseases of urinary system | 0.23 | 0.08 | 0.59 | 0.0027 | ** |
| ICD_Title(N40-N51) Diseases of male genital organs | 0.42 | 0.15 | 1.19 | 0.0975 | . |
| ICD_Title(N60-N64) Disorders of breast | 0.04 | 0.02 | 0.09 | 0.0000 | *** |
| ICD_Title(N70-N77) Inflammatory diseases of female pelvic organs | 0.27 | 0.10 | 0.69 | 0.0065 | ** |
| ICD_Title(N80-N98) Noninflammatory disorders of female genital tract | 0.42 | 0.18 | 0.97 | 0.0439 | * |
| ICD_Title(O20-O29) Other maternal disorders predominantly related to pregnancy | 0.17 | 0.01 | 1.88 | 0.1585 |
|
| ICD_Title(O60-O75) Complications of labour and delivery | 0.68 | 0.12 | 5.22 | 0.6718 |
|
| ICD_Title(O85-O92) Complications predominantly related to the puerperium | 0.05 | 0.02 | 0.12 | 0.0000 | *** |
| ICD_Title(Q38-Q45) Other congenital malformations of the digestive system | 0.60 | 0.23 | 1.66 | 0.3163 |
|
| ICD_Title(Q50-Q56) Congenital malformations of genital organs | 1.02 | 0.12 | 21.38 | 0.9867 |
|
| ICD_Title(Q80-Q89) Other congenital malformations | 0.68 | 0.16 | 3.50 | 0.6122 |
|
| ICD_Title(Q90-Q99) Chromosomal abnormalities, not elsewhere classified | 0.34 | 0.01 | 8.91 | 0.4543 |
|
| ICD_Title(R10-R19) Symptoms and signs involving the digestive system and abdomen | 0.30 | 0.15 | 0.56 | 0.0002 | *** |
| ICD_Title(R20-R23) Symptoms and signs involving the skin and subcutaneous tissue | 0.22 | 0.08 | 0.58 | 0.0029 | ** |
| ICD_Title(S30-S39) Injuries to the abdomen, lower back, lumbar spine and pelvis | 1.70 | 0.59 | 5.65 | 0.3473 |
|
| ICD_Title(S80-S89) Injuries to the knee and lower leg | 0.68 | 0.06 | 15.17 | 0.7589 |
|
| ICD_Title(T36-T50) Poisoning by drugs, medicaments and biological substances | 0.07 | 0.01 | 0.29 | 0.0011 | ** |
| ICD_Title(T51-T65) Toxic effects of substances chiefly nonmedicinal as to source | 0.04 | 0.01 | 0.16 | 0.0001 | *** |
| ICD_Title(T80-T88) Complications of surgical and medical care, not elsewhere classified | 1.19 | 0.37 | 4.64 | 0.7833 |
|
| ICD_Title(W75-W84) Accidents: Other external causes of accidental injury: Other accidental threats to breathing | 0.11 | 0.01 | 0.95 | 0.0669 | . |
| ICD_Title(X60-X84) Intentional self-harm | 0.07 | 0.00 | 0.46 | 0.0174 | * |
| ICD_Title(Z00-Z13) Persons encountering health services for examination and investigation | 0.34 | 0.01 | 8.91 | 0.4543 |
|
| ICD_Title(Z40-Z54) Persons encountering health services for specific procedures and health care | 1.43 | 0.49 | 4.79 | 0.5329 |
|
| ICD_Title(Z80-Z99) Persons with potential health hazards related to family and personal history and certain conditions influencing health status | 0.56 | 0.26 | 1.19 | 0.1327 |
|
| Elements | Results | |
|---|---|---|
| Chi Squared | 827.8724 |
|
| Degrees of Freedom | 111.0000 |
|
| p Value | 0.0000 | *** |